H.C. Wainwright Maintains Exelixis(EXEL.US) With Buy Rating, Raises Target Price to $40

Futu NewsJan 10 19:31 · Ratings

Express News | Exelixis, Inc. : H.c. Wainwright Raises Target Price to $40 From $29

BreakingsJan 10 19:20

RBC Capital Remains a Buy on Exelixis (EXEL)

TipRanksJan 10 09:49 · Ratings

Citi Maintains Exelixis(EXEL.US) With Buy Rating, Maintains Target Price $38

Futu NewsJan 10 01:31 · Ratings

Positive FDA Signal and Growth Prospects Drive Buy Rating for Exelixis

TipRanksJan 10 01:05 · Ratings

Express News | Exelixis: Snda Remains Under Consideration by FDA With Pdufa Date of April 3, 2025

BreakingsJan 9 22:07